Clinical trial
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and…
NCT00463606 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00463606 |
|---|---|
| Title | A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia |
| Official title | A 12-week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to ABT-335 and Rosuvastatin Monotherapy in Subjects With Type IIa and IIb Dyslipidemia |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Dyslipidemia |
| Intervention type | Drug |
| Interventions | ABT-335 and rosuvastatin calcium, ABT-335, rosuvastatin calcium |
| Enrollment | 760 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Apr 20, 2007 |
| Last update posted | Oct 3, 2012 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: